Synthesis and in vitro T-cell immunogenicity of conjugates with dual specificity: Attachment of epitope peptides of 16 and 38 kDa proteins from Mycobacterium tuberculosis to branched polypeptide

Bioconjugate Chemistry

Volumn 9, Issue 5, 1998, Pages 539-547

  Wilkinson, Katalin A ^a   Vordermeier, Hans ^b   Wilkinson, R J ^b   Ivanyi, Juraj ^b   Hudecz, Ferenc ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC TEST; EPITOPE; HYBRIDOMA; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; PROTEIN SYNTHESIS; SYNTHETIC PEPTIDE; THYMOCYTE; VACCINE PRODUCTION;

AMINO ACIDS; BIODEGRADABLE POLYMERS; BIOSYNTHESIS; CHAINS; COVALENT BONDS; CYTOLOGY; EPITOPES; LACTIC ACID; POLYPEPTIDES; SULFUR COMPOUNDS; T-CELLS;

CARBOXYL GROUPS; CELL IMMUNOGENICITY; EPITOPE PEPTIDE; IMMUNOGENS; IN-VITRO; MYCOBACTERIUM TUBERCULOSIS; POLY-L-LYSINE; SIDE-CHAINS; T-CELL EPITOPES; TEST DIAGNOSTICS;

PEPTIDES;

EID: 0032170489     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970159+     Document Type: Article

References (46)

1. Del Giudice, G. (1992) New carriers and adjuvants in the development of vaccines. Curr. Opin. in Immunol. 4, 454-459.
2. Hudecz, F., and Tóth, G. K. (1994) Synthetic peptide constructs to increase the immunogenicity of B-cell epitopes. Synthetic peptides in the search for B- and T-cell epitopes (É. Rajnavölgyi, Ed.) pp 97-119, R. G. Landes Company, Austin.
3. Delpierre, C., Martin, C., Gequiere, J. C., Tartar, A., Cachera, C., Puchois, P., Fievet, C., and Fruchart, J. C. (1987) Chemical approach to synthetic immunogens in clinical chemistry. Int. J. Rad. Appl. 14, 281-288.
4. Wan, A. M., Langton, B. C., Andria, M. L., and Benjamini, E. (1986) Antigenic requirements for T-cell activation. Mol. Immunol. 23, 467-474.
5. Scheerlinck, J. P., Michel, A., and De Baetselier, P. (1994) Grafting of a hepatitis B S-preS(2) T-cell epitope on lysozyme enhances the immunogenicity of lysozyme in responder mice primed with the T-cell epitope. Immunol. Lett. 41, 25-32.
6. Helling, F., Shang, A., Calves, M., Zhang, S., Ren, S., Yu, R. K., Oettgen, H. H., and Livingston, P. O. (1994) GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Res. 54, 197-203.
7. Konen-Waisman, S., Fridkin, M., and Cohen, I. R. (1995) Self- and foreign 60-kDa heat shock protein T-cell epitope peptides serve as immunogenic carriers for a T-cell-independent sugar antigen. J. Immunol. 154, 5977-5985.
8. Lett, E., Klopfenstein, C., Klein, J. P., Scholler, M., and Wachsman, D. (1995) Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes. Infect. Immun. 63, 2645-2651.
9. Hudecz, F., Votavova, H., Gaál, D., Sponar, J., Kajtár, J., Blaha, K., and Szekerke, M. (1985) Branched polypeptides with a poly(L-lysine) backbone: synthesis, conformation and immunomodulation. Polymeric Materials in Medication (Ch. G. Gebelein, and Ch. E. Carraher, Eds.) pp 265-289, Plenum Press, New York.
10. Hudecz, F. (1995) Design of synthetic branched-chain polypeptides as carriers for bioactive molecules. Anti-Cancer Drugs 6, 171-193.
11. Sela, M. (1980) Chemical synthesis for the understanding of immune response phenomena and for their medical application. Molecules, cells, and parasites in immunology (C. Larralde, K. Wills, L. Ortiz-Ortiz, and M. Sela, Eds.) pp 215-228, Academic Press, New York.
12. Hudecz, F., and Szekerke, M. (1980) Investigation of drug-protein interactions and the drug-carrier concept by the use of branched polypeptides as model systems. Synthesis and characterisation of the model peptides. Collect. Czech. Chem. Commun. 45, 933-940.
13. Hudecz, F., and Szekerke, M. (1985) Synthesis of new branched polypeptides with poly(lysine) backbone. Collect. Czech. Chem. Commun. 50, 103-113.
14. Hudecz, F. (1995) Alteration of immunogenicity and antibody recognition of B-cell epitopes by synthetic branched polypeptide carriers with poly[L-lysine Backbone. Biomed. Pept., Proteins Nucleic Acids 1, 213-220.
15. Hudecz, F., Kajtár, J., Kurucz, I., and Szekerke, M. (1988) Investigation of the carrier function of polypeptides. Synthesis, conformation and cytotoxicity of oxaziolone conjugates of poly[Lys] and poly[Lys-(DL-Alam)]. Makromol. Chem. Macromol. Symp. 19, 107-124.
16. m/backbone. Mol. Immunol. 26, 949-958.
17. Hudecz, F., and Price, M. R. (1992) Monoclonal antibody binding to peptide epitopes conjugated to synthetic branched polypeptide carriers. Influence of the carrier upon antibody recognition. J. Immunol. Methods 147, 201-210.
18. Hudecz, F., Hilbert, A., Mezö, G., Mucsi, I., Kajtár, J., Bösze, Sz., Kurucz, I., and Rajnavölgyi, É. (1993) Epitope mapping of the 273-284 region of HSV glycoprotein D by synthetic branched polypeptide carrier conjugates. Peptide Res. 6, 263-271.
19. Ivanyi, J., and Thole, J. (1994) Specificity and function of T- and B-cell recognition in tuberculosis. Tuberculosis: Pathogenesis, Protection and Control (B. R. Bloom. Ed.) pp 437-458, ASM Press, Washington, DC.
20. Andersen, P. (1994) Effective vaccination of mice against M. tuberculosis infection with a solube mixture of secreted mycobacterial proteins. Infect. Immun. 62, 2526-2544.
21. Chugh, I. B., and Khuller, G. K. (1993) Immunoprotective behaviour of liposome entrapped cell wall subunit of M. tuberculosis against experimental infection in mice. Eur. Respir. J. 6, 811-815.
22. Vordermeier, H. M., Coombes, A. G., Jenkins, P., McGee, J. P., O'Hagan, D. T., Davis, S. S., and Singh, M. (1995) Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine 13, 1576-1582.
23. Harboe, M., and Wiker, H. G. (1992) The 38 kDa protein of M. tuberculosis: a review. J. Infect. Dis. 166, 874-884.
24. Andersen, A. B., and Hansen, EB. (1989) Structure and mapping of antigenic domains of protein antigen b, a 38,000 molecular weight protein of M. tuberculosis. Infect. Immun. 57, 2481-2488.
25. Cole, R. A., Lu, H. M., Shi, Y. Z., Wang, J., De-Hua, T., and Zhou, A. T. (1996) Clinical evaluation of a rapid immunochromatographic assay based on the 38 kDa antigen of Mycobacterium tuberculosis on patients with pulmonary tuberculosis in China. Tubercle Lung Dis. 77, 363-368.
26. Vordermeier, H. M., Harris, D. P., Roman, E., Lathigra, R., Moreno, C., and Ivanyi, J.(1991) Identification of T-cell stimulatory peptides from the 38 kDa protein of M. tuberculosis, J. Immunol. 147, 1023-1029.
27. Vordermeier, H. M., Harris, D. P., Moreno, C., Singh, M., and Ivanyi, J. (1995) The nature of the immunogen determines the specificity of antibodies and T-cells to selected peptides of the 38 kDa mycobacterial antigen. Int. Immunol. 7, 559-566.
28. Pollock, J. M., Douglas, A. J., Mackie, D. P., and Neill, S. D. (1995) Peptide mapping of bovine T-cell epitopes for the 38 kDa tunerculosis antigen. Scand. J. Immunol. 41 85-93.
29. Vordermeier, H. M., Harris, D. P., Friscia, G., Roman, E., Surcel, H. M., Moreno, C., Pasvol, G., and Ivanyi, J. (1992) T-cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. Eur. J. Immunol, 22, 2631-2637.
30. Jackett, P. S., Bothamley, G. H., Batra, H. V., Mistry, A., Young, D. B., and Ivanyi, J. (1988) Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis. J. Clin. Microbiol. 26, 2313-2318.
31. Lee, B. Y., Hefta, S. A., and Brennan, P. J. (1992) Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect. Immun. 60, 2066-2074.
32. Chang, Z., Primm, T. P., Jakana, J., Lee, I. H., Serysheval, I., Chiu, W., Gilbert, H. F., and Quiocho, F. A. (1996) M. tuberculosis 16 kDa antigen (HSP16.3) functions as an oligomeric structure in vitro to suppress thermal aggregation. J. Biol. Chem. 271, 7218-7223.
33. Kingston, A. E., Padmini, R. S., Mitchison, N. A., and Colston, M. J. (1987) Immunological activity of a 14-kilodalton recombinant protein of Mycobacterium tuberculosis H37Rv. Infect. Immun. 55, 3149-3154.
34. Vordermeier, H. M., Harris, D. P., Lathigra, R., Roman, E., Moreno, C., and Ivanyi, J. (1993) Recognition of peptide epitopes of the 16,000 MW antigen of Mycobacterium tuberculosis by murine T-cells. Immunology 80, 6-12.
35. Friscia, G., Vordermeier, H. M., Pasvol, G., Harris, D. P., Moreno, C., and Ivanyi, J. (1995) Human T-cell responses to peptide epitopes of the 16-kD antigen in tuberculosis. Clin. Exp. Immunol. 102, 53-57.
36. Hudecz, F., Kojima, Y., Miyamoto, Y., Kajtár, J., and Maeda, H. (1994) The effect of charge on the biodistribution of synthetic branched polypeptides in tumour bearing mice. J. Controlled Release 28, 301-302.
37. Kaiser, E., Colescott, R. L., Bossinger, C. D., and Cook, P. I. (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34, 595-598.
38. Krchnak, V., Vagner, J., Safar, P., and Lebl, M. (1988) Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator. Collect. Czech. Chem. Commun. 53, 2542-2548.
39. IUPAC-IUB Commission on Biochemical Nomenclature (1972) Biochem. J. 127, 753-756.
40. IUPAC-IUB Commission on Biochemical Nomenclature (1984) Eur. J. Biochem. 138, 9-37.
41. Hudecz, F., Kovács, P., Kutassi-Kovács, S., and Kajtár, J. (1984) GPC, CD and sedimentation analysis of poly-Lys and branched chain poly-Lys-poly-DL-Ala polypeptides. Colloid Polymer Sci. 262, 208-212.
42. Mezö, G., Mezö, I., Pimm, M. V., Kajtár, J., Seprödi, J., Teplán, I., Kovács, M., Vincze, B., Pályi, I., Idei, M., Szekerke, M., and Hudecz, F. (1996) Synthesis, conformation, biodistribution and hormone-related in vitro antitumor activity of a gonadotropin-releasing hormone antagonist-branched polypeptide conjugate. Bioconjugate Chem. 7, 642-650.
43. Carlsson, J., Drevin, H., and Axen, R. (1978) Protein thiolation and reversible protein-protein conjugation. N-succinimidyl-3-(2-pyridyl-dithio)propionate, a new heterobifunctional reagent. Biochem. J. 173, 723-728.
44. Stuchbury, T., Shipton, M., Norris, R., Malthouse, JPG., Brocklehurst, K., Hebert, J. A. L., and Suschitzky, H. (1975) A reporter group delivery system with both absolute and selevtive specificity for thiol groups and an improved fluorescent probe containing the 7-nitrobenzo-2-oxa-1,3-diazole moiety. Biochem. J. 151, 417-432.
45. Singh, M., Andersen, A. B., McCarthy, J. E. G., Rhode, M., Schütte, H., Sanders, E., and Timmis, K. N. (1992) The Mycobacterium tuberculosis 38 kDa antigen: overproduction in Escherichia coli, purification and characterisation, Gene 117, 53-60.
46. Vordermeier, H. M., Arya, A., Harris, D. P., Moreno, C., and Ivanyi, J. (1995) Abundance of H-2 promiscuous T-cells specific for mycobacterial determinants in H-2b/d F1 hybrid mice. Eur. J. Immunol. 25, 2770-2774.